Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
---|
03/02/2005 | EP1510211A1 Pharmaceutical composition comprising N-retinyl-N-retinylidene Ethanolamine (A2E), isoforms of A2E or derivatives thereof |
03/02/2005 | EP1509254A1 New agents for magnetic imaging method |
03/02/2005 | EP1509246A2 Thermosensitive polymer carriers having a modifiable physical structure for biochemical analysis, diagnosis, and therapy |
03/02/2005 | EP1509237A2 Methods of treating angiogenesis, tumor growth, and metastasis |
03/02/2005 | EP1509224A1 Methods using a combination of a 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia |
03/02/2005 | EP1509129A2 Sensitized online bold-mri imaging method |
03/01/2005 | US6860879 Use of 5-aminolevulinic acid or a derivate thereof for photodynamic diagnosis and/or photodynamic therapy |
02/24/2005 | WO2005017522A2 Method for in vivo determination on tested animals of the efficient concentration of deuterium depleted water for cancer therapy |
02/24/2005 | WO2005016369A1 Use of a vegf antagonist in combination with radiation therapy |
02/24/2005 | WO2004112708A3 Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals |
02/24/2005 | US20050043726 Device II |
02/24/2005 | US20050043323 Pyrimidylpyrrole derivatives active as kinase inhibitors |
02/24/2005 | CA2534197A1 Use of a vegf antagonist in combination with radiation therapy |
02/24/2005 | CA2525624A1 Method for in vivo determination on tested animals of the efficient concentration of deuterium depleted water for cancer therapy |
02/23/2005 | EP1507556A2 Calicheamicin derivative-carrier conjugates |
02/23/2005 | CN1583762A Axial substituted phthalocyanine compound, its preparation and application in optical kinetic treatment |
02/22/2005 | US6858598 Administering N-hydroxy-2,2-dimethyl-4-((4-(4-pyridinyloxy)phenyl)sulfonyl)-3 -thiomorpholinecarboxamide and an antineoplastic agent selected from irinotecan and topotecan and a combination thereof for therapy of lung cancer |
02/17/2005 | WO2005014572A1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
02/17/2005 | WO2005014019A1 Markov therapeutic and preventive compound |
02/17/2005 | WO2005014003A1 Topical use of tyrosine kinase inhibitors of microbial origin to prevent and treat skin disorders characterised by excessive cell proliferation |
02/17/2005 | WO2004092115A3 Hydroxamates as therapeutic agents |
02/17/2005 | WO2004091592A3 Methods and compositions to treat myocardial conditions |
02/17/2005 | WO2004028338A3 A method to demonstrate the efficacy of pharmacological stress agent |
02/17/2005 | WO2004018471A9 Nucleic acid damage using riboflavin and light |
02/17/2005 | US20050037401 Photocleavable DNA transfer agent |
02/17/2005 | US20050037090 Selected from Vitaxin, exemestane, anastrozole, letrozole, thiotepa, SU-5416, capecitabine, tamoxifen, raloxifene, fluoxymesterone, megestrol, toremifene, goserelin, ornithine decarboxylase inhibitors such as eflornithine, bisphosphonates and sulindac sulfone |
02/17/2005 | CA2534687A1 Magnetic nanoparticle compositions, and methods related thereto |
02/17/2005 | CA2534496A1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
02/16/2005 | EP1506285A2 Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
02/16/2005 | EP1506014A1 Process for the preparation and activation of substances and a means of producing same |
02/16/2005 | EP1506011A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
02/16/2005 | EP1505993A1 Sensitization of neoplastic cells to radiation therapy with oncolytic viruses |
02/16/2005 | EP1505984A2 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury |
02/16/2005 | CN1582166A Vitronectin receptor antagonist pharmaceuticals for use in combination therapy |
02/10/2005 | WO2005011810A1 Magnetic particles for therapeutic treatment |
02/10/2005 | WO2005011752A1 Method of sterilization by irradiation of polymeric materials suitable for therapeutical purposes |
02/10/2005 | WO2004093856A3 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia |
02/10/2005 | US20050032769 Treatment of tumors by irradiating with light after administration of protoporphyrin derivative; ethylene glycol esters of monohydrobenzoporphyrins |
02/10/2005 | US20050031542 using carbocyanine dyes; photodynamic therapy; supplying to tumors |
02/10/2005 | US20050031541 Diagnosis and treatment of cervical and bladder cancer using hexyl 5-aminolevulinate as a photosensitizer; improved photochemotherapeutic properties; antineoplastic agents |
02/09/2005 | EP1503806A1 Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer |
02/09/2005 | EP1503802A2 Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier |
02/09/2005 | EP1503796A1 Compositions and methods for delivery of photosensitive drugs |
02/09/2005 | EP1503770A1 Method for extended storage of blood and blood components |
02/09/2005 | EP1503756A1 Epothilone derivative for the treatment of hepatoma and other cancer diseases |
02/09/2005 | EP1503734A2 Methods and apparatus for modifying properties of the bbb and cerebral circulation by using the neuroexcitatory and/or neuroinhibitory effects of odorants on nerves in the head |
02/08/2005 | US6852252 Nanoshells (e.g., gold nanoshells) interact with triplet excitons, halting photo-oxidation of photo-conductive polymers (e.g., poly(3-octylthiophene)); stable material can be used in light emitting- and photo-diodes. |
02/03/2005 | WO2003070890A3 THE p65 SUBUNIT OF NF-κB FOR THE RADIOSENSITIZATION OF CELLS |
02/02/2005 | EP1501524A2 Internal image antibodies for optical imaging and therapy |
02/02/2005 | EP1501522A2 Preblocking with non-ha gags increases effectiveness of ha conjugated anticancer agents |
02/02/2005 | EP1501437A1 Low intensity light therapy for the manipulation of fibroblast-derived mammalian cells and collagen |
02/02/2005 | EP1404334A4 Targeted delivery of bioaffecting compounds for the treatment of cancer |
02/02/2005 | CN1187089C Application of photosensitizer in preparing medicine for lightening and preventing inflammation of damnified tissue |
02/01/2005 | US6849058 Treating rheumatoid arthritis by administering a photoactive compound such as a porphyrin systemically, directly to an affected joint or extracorporally to blood and irradiating to effect activation; returning blood to body |
01/27/2005 | WO2005007837A1 Irradiated osteoinductive extracellular material |
01/27/2005 | US20050020869 Methods of enhancing radiation effects with metal nanoparticles |
01/27/2005 | US20050020560 Fusion using acid catalyst |
01/27/2005 | US20050020559 Vision defects; cardiovascular disorders; skin disorders; anticancer agents |
01/27/2005 | US20050019266 Therapeutic ultrasond; imaging vascular plaque; administering contrast agent in aqueous carrier; scanning |
01/27/2005 | US20050019264 Imaging tissue with contrast agent such as Rose Bengal; medical diagnosis |
01/26/2005 | EP1499746A1 Method to inhibit cell growth using oligonucleotides |
01/26/2005 | EP1499321A2 Methods for increasing the therapeutic response to electroconvulsive therapy ("ect") |
01/26/2005 | EP1499315A1 Combination of cyclooxygenase-2 inhibitors and thalidomide for the treatment of neoplasia |
01/26/2005 | EP1283047A4 Method for producing a bioactive substance from blood serum |
01/26/2005 | EP0831909B1 Use of a protoporphyrin ix precursor in the treatment of dermatophytoses and malaria after photoactivation of said protoporphyrin |
01/26/2005 | CN1571834A Cell therapy method for the treatment of tumors |
01/25/2005 | CA2174209C Phosphorescent compounds for imaging tissue oxygen |
01/20/2005 | WO2005004972A1 Sonophoresis skin care device |
01/20/2005 | WO2005004872A1 Cancer combination therapy comprising azd2171 and zd1839 |
01/20/2005 | WO2005004870A1 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability |
01/20/2005 | WO2005004790A2 Liquid massage composition for the cure of acute chronic vertebral hernia, diseases of joint, arthritis, calcification and for the regulation of blood circulation |
01/20/2005 | WO2005004781A1 Non-invasive intravascular thrombolyisis using modified ultrasound techniques |
01/20/2005 | WO2005004720A1 System to generate therapeutic radiation |
01/20/2005 | US20050013875 Immunopotentiators in thermotherapy for cancer |
01/20/2005 | US20050013780 Hollow microspheres with controlled fragility for medical use |
01/20/2005 | CA2531025A1 Process for the preparation of micron-size crystalline particles using a solvent, a non-solvent and ultrasonic energy |
01/20/2005 | CA2529304A1 Non-invasive intravascular thrombolysis using modified ultrasound techniques |
01/19/2005 | EP1496947A1 Removal of adenine during a process of pathogen reducing blood and blood components |
01/19/2005 | EP1496933A2 Use of interleukin-19 to treat ovarian cancer |
01/19/2005 | EP1496925A2 Use of interleukin-24 to treat ovarian cancer |
01/19/2005 | EP1496860A1 Localized non-invasive biological modulation system |
01/19/2005 | EP1272199B1 Combination therapies with vascular damaging activity |
01/19/2005 | CN1568187A 2H-2, 3-dinitrogen phenodiazine-1-ketone and using method thereof |
01/18/2005 | US6844429 Fullerene derivative and composition comprising the same |
01/18/2005 | US6843961 Deactivation pathogens; using riboflavin sensitizers; exposure to light source |
01/13/2005 | WO2004089409A3 Agent for the photodynamic diagnosis and therapy of malignant tumors |
01/13/2005 | US20050010112 Ultrasound assembly with increased efficacy |
01/13/2005 | US20050009913 By adding as a precursor compound delta -aminolevulinic acid or a derivative from which photosensitizers are formed by endogenous synthesis, and subsequent photodynamic treatment |
01/13/2005 | US20050009802 Tertiary amino-substituted, e.g, 1(4),8(11),15(18),22(25)-tetrakis[(3-(dimethylamino)phenoxy)phthalocyaninato] zinc; and their use as photodynamic therapeutic and photodiagnostic agents. |
01/13/2005 | US20050008569 Contract agent for imaging; ultrasonic , magnetic resonance imaging, computer temography; gadolinum, or compound thereof, encapsulated in shell; cancer therapy |
01/12/2005 | EP1494752A1 Method of treating biological materials with translating electrical fields and electrode polarity reversal |
01/12/2005 | EP1494694A2 Photo-active backbone cyclized somatostatin analogs for photodynamic therapy and imaging |
01/11/2005 | US6841538 Combination therapy using nucleic acids and radio therapy |
01/11/2005 | US6841537 Combination therapy using nucleic acids and conventional drugs |
01/06/2005 | WO2005000352A1 Method of reducing the harmful effects of orally or transdermally delivered nicotine |
01/06/2005 | WO2005000341A1 Use of cytosolic phospholipid hydroperoxide glutathione peroxidase to reduce tumor growth |
01/06/2005 | US20050004510 Noninvasive vascular therapy |
01/06/2005 | US20050003007 Method of sterilization of polymeric microparticles |
01/06/2005 | CA2527648A1 Method of reducing the harmful effects of orally or transdermally delivered nicotine |
01/05/2005 | EP1492560A2 Use of interleukin-19 to treat cervical cancer |